企業プロフィール
PaxMedica 株価・ニュース・カタリスト
- ティッカー:
- PXMD
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (+14.29%)
終値
最終更新: 2026年8月20日
—
時価総額
株価変動の要因
Current closing-price context is not available for PXMD.
企業概要
事業概要
PaxMedica is a biotechnology company focused on neurodevelopmental disorders and other high-unmet-need conditions. Its story is centered on using a small pipeline to address difficult patient populations.
所在地とセクター分類
PaxMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
ビジネスモデルの特徴
The company depends on clinical progress, capital efficiency, and the ability to keep a narrow pipeline moving. Investors usually watch early data and whether the company can sharpen its thesis.
バイオ業界での位置付け
PaxMedica occupies a speculative small-cap biotech niche. It is catalyst-sensitive because the company is still proving its therapeutic relevance.
今後のカタリスト
- PaxMedica’s catalysts are PAX-101 and the neurodevelopment / rare-disease programs, where any update can materially change sentiment. The stock remains highly data-dependent.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。